[1]
“NANOPARTICLE-BASED MODULATION OF NEURONAL ACTIVITY AND NEUROPROTECTION IN PARKINSON’S AND ALZHEIMER’S DISEASE”, RMSR, vol. 4, no. 6, pp. 1071–1101, Jun. 2026, Accessed: Aug. 14, 2026. [Online]. Available: https://medicalsciencereview.com/index.php/Journal/article/view/3894